What is FARMACEUTICALRX?
FARMACEUTICALRX is a vertically integrated, multi-state operator and therapeutics company dedicated to advancing the medical marijuana industry through rigorous research and development. The company holds licenses to provide high-quality medical marijuana therapeutics to patients across key markets, including Ohio and Pennsylvania. FARMACEUTICALRX's operations are driven by a distinguished team of scientists, healthcare professionals, and cannabis industry experts focused on discovering, developing, and manufacturing innovative products.
How much funding has FARMACEUTICALRX raised?
FARMACEUTICALRX has raised a total of $74.5M across 5 funding rounds:
Share Placement
$8M
Series A
$10M
Debt
$21M
Debt
$34M
Private Equity
$1.5M
Share Placement (2019): $8M with participation from Undisclosed
Series A (2019): $10M led by Undisclosed
Debt (2021): $21M supported by AFC Gamma
Debt (2022): $34M featuring Chicago Atlantic Real Estate
Private Equity (2022): $1.5M backed by KEY Investment Partners
Key Investors in FARMACEUTICALRX
Chicago Atlantic Real Estate
Chicago Atlantic Real Estate Finance, Inc. is a commercial real estate finance company that specializes in providing first mortgage loans to state-licensed operators within the cannabis industry, secured by various assets of the borrowers.
KEY Investment Partners
KEY Investment Partners is a U.S.-based private equity and venture capital firm with a dedicated focus on the cannabis industry, investing in high-growth companies across the value chain.
AFC Gamma
AFC Gamma is a significant debt provider, offering financing solutions to cannabis-related businesses, often secured by real estate and other assets.
What's next for FARMACEUTICALRX?
The substantial enterprise-level funding FARMACEUTICALRX has attracted signals a strategic phase of scaling and expansion. This capital infusion is expected to fuel further research and development initiatives, enhance its vertically integrated operational platform, and potentially broaden its market reach. The company's focus on therapeutic innovation positions it to capitalize on evolving healthcare landscapes and patient needs within the regulated cannabis market.
See full FARMACEUTICALRX company page
